Product NDC: | 0378-3633 |
Proprietary Name: | Carvedilol |
Non Proprietary Name: | carvedilol |
Active Ingredient(s): | 12.5 mg/1 & nbsp; carvedilol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-3633 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077316 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120815 |
Package NDC: | 0378-3633-05 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3633-05) |
NDC Code | 0378-3633-05 |
Proprietary Name | Carvedilol |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3633-05) |
Product NDC | 0378-3633 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | carvedilol |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120815 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | CARVEDILOL |
Strength Number | 12.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC] |